Related Experiment Video
Updated: Feb 25, 2026
07:28
Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
Published on: April 6, 2017
41.6K
New Treatment Option for Chronic Obstructive Pulmonary Disease: Two Long-Acting Bronchodilators in a Single
Timothy H Self1, Samantha Ellingson2
1University of Tennessee Health Science Center, Methodist University Hospital, Memphis.
The American Journal of Medicine
|August 1, 2017
Summary
Long-acting inhaled bronchodilators, including long-acting muscarinic antagonist/long-acting beta2 agonist combinations, improve lung function and quality of life in COPD patients. Proper inhaler technique education is crucial for effective treatment across different devices.
Area of Science:
- Pulmonary Medicine
- Pharmacology
Background:
- Long-acting inhaled bronchodilators are essential for managing moderate to very severe chronic obstructive pulmonary disease (COPD).
- Glycopyrrolate (a long-acting muscarinic antagonist, LAMA) and formoterol fumarate (a long-acting beta2 agonist, LABA) combination therapy is a key treatment option.
Purpose of the Study:
- To review the efficacy of LAMA/LABA combination therapy in COPD.
- To discuss the available inhalation device options for LAMA/LABA therapy.
- To emphasize the importance of patient education and device selection.
Main Methods:
- Review of randomized controlled trials (RCTs) evaluating LAMA/LABA combination inhalers.
- Discussion of patient-centric factors influencing device selection.
- Emphasis on evidence-based guidelines for inhalation device use.
Main Results:
- LAMA/LABA combination therapy in a metered-dose inhaler demonstrated effectiveness in improving pulmonary function and quality of life in COPD patients.
- Three primary inhalation delivery systems are available: metered-dose inhaler, dry-powder inhaler, and Soft Mist inhaler.
- Patient factors like cognitive ability, manual dexterity, and inspiratory flow impact device choice.
Conclusions:
- LAMA/LABA combination therapy is effective for moderate to very severe COPD.
- Selection of the appropriate inhalation device should be individualized based on patient characteristics.
- Consistent patient education and observation of inhaler technique are critical for optimal therapeutic outcomes and adherence.
Related Concept Videos
01:23Inhaled Medications
899
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
899
01:26COPD: Management Using Bronchodilators and Corticosteroids
942
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
942
01:29Chronic Obstructive Pulmonary Disease-V: Management
3.3K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.3K
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
1.9K
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
1.9K
01:17Drugs Used in Lower Respiratory Disorders: Overview
1.3K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.3K
01:30Asthma-IV: Diagnostic and Management
3.2K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.2K